Xora Innovation

Xora Innovation is a venture capital investment firm based in Singapore, established in 2020. The company focuses on early-stage deep tech ventures, aiming to accelerate their path to market. It primarily invests in three key sectors: computing and communications, climate and energy, and artificial intelligence in physical industries. Xora Innovation emphasizes opportunities in Asia and North America, with a particular focus on energy, renewable energy, and biotechnology. By targeting disruptive and transformative deep science ventures, Xora Innovation seeks to support companies that have the potential to create significant global impact.

Philippe Inagaki

Managing Partner and Chief Investment Officer

Joel Leong

Director, Research and Analytics

Candice Ong

COO and Partner

Donna See

CEO

Alan Thompson

Interim CEO

Phoebe Tan Ph.D

Partner

20 past transactions

Summit Nanotech

Venture Round in 2025
Summit Nanotech Corporation is a cleantech company based in Calgary, Canada, focused on revolutionizing lithium extraction to support the global energy transition. Founded in 2018, the company specializes in a patented direct lithium extraction (DLE) technology that aims to provide sustainable and economically viable solutions for lithium producers. By collaborating with mining companies and lithium asset owners in regions such as Chile and Argentina, Summit Nanotech seeks to optimize operations and conserve natural resources while minimizing environmental impact. The company's innovative approach positions it as a leader in developing cost-effective solutions for the growing demand for battery-grade lithium.

Celestial AI

Series C in 2025
Celestial AI is a prominent artificial intelligence company that provides an advanced platform for users to efficiently create images, text, and presentations. Utilizing cutting-edge computer vision algorithms and natural language processing, the platform produces high-quality visual and textual content. Its intuitive design, combined with innovative features, facilitates easy content creation. Moreover, Celestial AI emphasizes intelligent data integration and prioritizes security, ensuring that users achieve impressive and reliable results.

Vsim Technology

Seed Round in 2024
Vsim Technology offers physics simulations technologies for AI, robotics, VFX, research and the industrial metaverse.

HyperLight

Series B in 2024
HyperLight specializes in the development of thin-film lithium niobate photonic integrated circuit solutions, focusing on reducing signal loss in various applications. The company designs and manufactures integrated optical circuits, including chip-scale LN modulators and photonic chips intended for data centers, datacom, and quantum computing. By converting signals between electricity and light waves, HyperLight's products set new performance benchmarks, enabling clients to achieve efficient operations with low power consumption. The company collaborates closely with its customers throughout the entire process, from conceptualization and design to prototyping and volume production, ensuring tailored solutions that meet specific needs.

Celestial AI

Series C in 2024
Celestial AI is a machine learning accelerator focused on developing an optical interconnect technology platform designed for data centers and AI applications. By leveraging photonics, mixed-signal ASICs, and advanced packaging, the company aims to enhance computing performance sustainably. Its Photonic Fabric technology serves as the foundation for optically scalable and disaggregated data center computing and memory, facilitating significant advancements in AI. Celestial AI’s solutions enable clients to deliver improved hardware and software alternatives for deep learning and machine learning, ultimately driving profitable and sustainable business models.

Amperesand

Seed Round in 2024
Amperesand is a grid infrastructure solution provider that specializes in developing advanced infrastructure systems for electrification. The company focuses on creating efficient, intelligent, and resilient electrical solutions using cutting-edge technology. Its offerings include silicon carbide (SiC) devices and proprietary high-frequency transformers, which are designed to be both flexible and durable. By leveraging these innovative components, Amperesand enables clients to effectively transform and manage electricity, enhancing the reliability and performance of their electrical systems.

Aether Fuels

Seed Round in 2023
Aether Fuels is an innovative climate technology company focused on creating sustainable fuels aimed at decarbonizing challenging sectors such as aviation and ocean shipping. The firm specializes in developing technologies that facilitate the efficient and cost-effective production of sustainable fuels from waste biomass and biogenic carbon dioxide. By enabling clients to produce practical and scalable sustainable fuels, Aether Fuels addresses the critical need for environmentally friendly alternatives in industries that are traditionally hard to decarbonize.

Talus Renewables

Series A in 2023
Talus Renewables offers new pathways to chemicals, fertilizers, and fuels with its green ammonia production technology.

Cosmos Innovation

Series A in 2023
Developer of artificial intelligence-driven solar cell technology platform designed to build next-generation cells. The company's platform technology offers perovskite silicon tandem solar cells that are optimized and improved based on data from those that came before and provides mainstream silicon technology that has a combination of materials and processes to reach its fundamental limits, enabling clients with new solar and semiconductor technologies in a fraction of the time and cost, compared to conventional methods.

Automera

Series A in 2023
Automera is a biotechnology company specializing in the development of innovative therapeutic methods for drug discovery. The firm focuses on creating autophagy-targeting drugs designed to address specific diseases. Utilizing advanced computational chemistry, artificial intelligence, and quantum molecular dynamics, Automera's technology enables the design of chimeric small molecules that can simultaneously bind to autophagy pathways and selected disease targets. This approach acts as a natural defense mechanism against viruses and bacteria, allowing for the identification and development of effective drugs that harness the body's own systems to combat diseases.

Allozymes

Series A in 2023
Allozymes is a prominent deep technology company that specializes in the application of ultrahigh-throughput microfluidics technology to enhance the evolution and development of enzymes. The company focuses on creating sensitive and accurate assays for enzymatic reactions, utilizing proprietary microfluidic chips and proteomics technologies. Allozymes' platform integrates molecular biology and process engineering to produce high-purity enzymes tailored for specific applications. This innovative approach enables clients to expedite custom enzyme development and to create novel, sustainable natural products, positioning Allozymes as a leader in the enzyme development sector.

Celestial AI

Series B in 2023
Celestial AI is a prominent artificial intelligence company that provides an advanced platform for users to efficiently create images, text, and presentations. Utilizing cutting-edge computer vision algorithms and natural language processing, the platform produces high-quality visual and textual content. Its intuitive design, combined with innovative features, facilitates easy content creation. Moreover, Celestial AI emphasizes intelligent data integration and prioritizes security, ensuring that users achieve impressive and reliable results.

Summit Nanotech

Series A in 2023
Summit Nanotech Corporation is a cleantech company based in Calgary, Canada, focused on revolutionizing lithium extraction to support the global energy transition. Founded in 2018, the company specializes in a patented direct lithium extraction (DLE) technology that aims to provide sustainable and economically viable solutions for lithium producers. By collaborating with mining companies and lithium asset owners in regions such as Chile and Argentina, Summit Nanotech seeks to optimize operations and conserve natural resources while minimizing environmental impact. The company's innovative approach positions it as a leader in developing cost-effective solutions for the growing demand for battery-grade lithium.

Think Bioscience

Seed Round in 2022
Think Bioscience is a company focused on advancing synthetic biology to enhance the development of medicines. It employs innovative technology to encode complex molecular objectives within microbial hosts, facilitating the identification, construction, and evolution of small molecules. By leveraging living systems, Think Bioscience aims to transform the drug discovery process, providing medical researchers with powerful tools to create better therapeutic solutions. The company's approach represents a significant evolution in the field of synthetic biology, positioning it as a leader in the quest for improved medicinal outcomes.

Summit Nanotech

Series A in 2022
Summit Nanotech Corporation is a cleantech company based in Calgary, Canada, focused on revolutionizing lithium extraction to support the global energy transition. Founded in 2018, the company specializes in a patented direct lithium extraction (DLE) technology that aims to provide sustainable and economically viable solutions for lithium producers. By collaborating with mining companies and lithium asset owners in regions such as Chile and Argentina, Summit Nanotech seeks to optimize operations and conserve natural resources while minimizing environmental impact. The company's innovative approach positions it as a leader in developing cost-effective solutions for the growing demand for battery-grade lithium.

SpeQtral

Venture Round in 2021
SpeQtral is a technology company focused on developing advanced quantum communication systems, particularly through satellite-based solutions. With a team of experts in quantum science, cryptography, and engineering, SpeQtral addresses the significant security challenges that arise from the advancements in quantum computing. The company's product portfolio includes both fibre- and satellite-based quantum key distribution systems, which provide security through physical principles rather than traditional computational methods. This innovative approach ensures that SpeQtral's technologies are resilient against current encryption vulnerabilities and are future-proof, enabling businesses to establish secure communication networks with an additional layer of quantum-secured encryption.

SpeQtral

Series A in 2021
SpeQtral is a technology company focused on developing advanced quantum communication systems, particularly through satellite-based solutions. With a team of experts in quantum science, cryptography, and engineering, SpeQtral addresses the significant security challenges that arise from the advancements in quantum computing. The company's product portfolio includes both fibre- and satellite-based quantum key distribution systems, which provide security through physical principles rather than traditional computational methods. This innovative approach ensures that SpeQtral's technologies are resilient against current encryption vulnerabilities and are future-proof, enabling businesses to establish secure communication networks with an additional layer of quantum-secured encryption.

Allozymes

Seed Round in 2021
Allozymes is a prominent deep technology company that specializes in the application of ultrahigh-throughput microfluidics technology to enhance the evolution and development of enzymes. The company focuses on creating sensitive and accurate assays for enzymatic reactions, utilizing proprietary microfluidic chips and proteomics technologies. Allozymes' platform integrates molecular biology and process engineering to produce high-purity enzymes tailored for specific applications. This innovative approach enables clients to expedite custom enzyme development and to create novel, sustainable natural products, positioning Allozymes as a leader in the enzyme development sector.

Nuevocor

Series A in 2021
Nuevocor is a preclinical-stage biopharmaceutical company dedicated to developing gene therapy-based treatments aimed at restoring cardiac function in hearts affected by disease. The company specializes in addressing genetic cardiomyopathies, which are characterized by abnormal mechanobiology. By focusing on modulating mechanical force transduction, Nuevocor seeks to provide innovative solutions that enable healthcare professionals to improve cardiac function in patients suffering from these conditions.

Nuevocor

Nuevocor is a preclinical-stage biopharmaceutical company dedicated to developing gene therapy-based treatments aimed at restoring cardiac function in hearts affected by disease. The company specializes in addressing genetic cardiomyopathies, which are characterized by abnormal mechanobiology. By focusing on modulating mechanical force transduction, Nuevocor seeks to provide innovative solutions that enable healthcare professionals to improve cardiac function in patients suffering from these conditions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.